Derivation, Culture, and Characterization of VUB HESC Lines

Overview

Journal In Vitro Cell Dev Biol Anim

Publisher Springer

Specialties Biology
Cell Biology

Date 2010 Mar 13

PMID 20224973

Citations 15

Authors

Ileana Mateizel

Claudia Spits

Martine De Rycke

Inge Liebaers

Karen Sermon

Affiliations

Soon will be listed here.

Abstract

In this report, we present the derivation and characterization of 15 hESC lines established at the Vrije Universiteit Brussel, Belgium in collaboration with the Universitair Ziekenhuis Brussel, Belgium, using surplus in vitro fertilization embryos and embryos carrying monogenic disorders donated for research. Four lines were derived from blastocyst-stage embryos presumed to be genetically normal, and 11 hESC lines were obtained from embryos shown to carry genetic mutations by preimplantation genetic diagnosis. All the lines express markers of pluripotency as determined by immunocytochemistry and RT-PCR, and formed teratomas when injected into SCID mice. All VUB hESC lines, except for VUB17, are reported in the European hESC registry and are available upon request after signing a Material Transfer Agreement from the VUB (contact person: Prof. Dr. Karen Sermon; Karen.Sermon@uzbrussel.be).

Citing Articles

Human stem cell models for Marfan syndrome: a .

Aalders J, Mosquera L, van Hengel J Front Cell Dev Biol. 2025; 12():1498669.

PMID: 39830211 PMC: 11739147. DOI: 10.3389/fcell.2024.1498669.

Gain of 1q confers an MDM4-driven growth advantage to undifferentiated and differentiating hESC while altering their differentiation capacity.

Krivec N, Couvreu de Deckersberg E, Lei Y, Al Delbany D, Regin M, Verhulst S Cell Death Dis. 2024; 15(11):852.

PMID: 39572522 PMC: 11582570. DOI: 10.1038/s41419-024-07236-x.

De Novo Cancer Mutations Frequently Associate with Recurrent Chromosomal Abnormalities during Long-Term Human Pluripotent Stem Cell Culture.

Al Delbany D, Ghosh M, Krivec N, Huyghebaert A, Regin M, Duong M Cells. 2024; 13(16).

PMID: 39195283 PMC: 11353044. DOI: 10.3390/cells13161395.

SALL3 mediates the loss of neuroectodermal differentiation potential in human embryonic stem cells with chromosome 18q loss.

Lei Y, Al Delbany D, Krivec N, Regin M, Couvreu de Deckersberg E, Janssens C Stem Cell Reports. 2024; 19(4):562-578.

PMID: 38552632 PMC: 11096619. DOI: 10.1016/j.stemcr.2024.03.001.

Uncovering low-level mosaicism in human embryonic stem cells using high throughput single cell shallow sequencing.

Keller A, Tilleman L, Dziedzicka D, Zambelli F, Sermon K, Van Nieuwerburgh F Sci Rep. 2019; 9(1):14844.

PMID: 31619727 PMC: 6796059. DOI: 10.1038/s41598-019-51314-6.

References

Sermon K, Van Steirteghem A, Liebaers I . Preimplantation genetic diagnosis. Lancet. 2004; 363(9421):1633-41. DOI: 10.1016/S0140-6736(04)16209-0. View

Spits C, Mateizel I, Geens M, Mertzanidou A, Staessen C, Vandeskelde Y . Recurrent chromosomal abnormalities in human embryonic stem cells. Nat Biotechnol. 2008; 26(12):1361-3. DOI: 10.1038/nbt.1510. View

De Temmerman N, Seneca S, VAN Steirteghem A, Haentjens P, Van der Elst J, Liebaers I . CTG repeat instability in a human embryonic stem cell line carrying the myotonic dystrophy type 1 mutation. Mol Hum Reprod. 2008; 14(7):405-12. DOI: 10.1093/molehr/gan034. View

Abeliovich A, Doege C . Reprogramming therapeutics: iPS cell prospects for neurodegenerative disease. Neuron. 2009; 61(3):337-9. PMC: 3659427. DOI: 10.1016/j.neuron.2009.01.024. View

Thomson J, Itskovitz-Eldor J, Shapiro S, Waknitz M, Swiergiel J, Marshall V . Embryonic stem cell lines derived from human blastocysts. Science. 1998; 282(5391):1145-7. DOI: 10.1126/science.282.5391.1145. View

Reubinoff B, Pera M, Fong C, Trounson A, Bongso A . Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol. 2000; 18(4):399-404. DOI: 10.1038/74447. View

Liu S . iPS cells: a more critical review. Stem Cells Dev. 2008; 17(3):391-7. DOI: 10.1089/scd.2008.0062. View

Pearson C, Edamura K, Cleary J . Repeat instability: mechanisms of dynamic mutations. Nat Rev Genet. 2005; 6(10):729-42. DOI: 10.1038/nrg1689. View

Spits C, Sermon K . PGD for monogenic disorders: aspects of molecular biology. Prenat Diagn. 2008; 29(1):50-6. DOI: 10.1002/pd.2161. View

10.

Mateizel I, De Temmerman N, Ullmann U, Cauffman G, Sermon K, van de Velde H . Derivation of human embryonic stem cell lines from embryos obtained after IVF and after PGD for monogenic disorders. Hum Reprod. 2005; 21(2):503-11. DOI: 10.1093/humrep/dei345. View

11.

Reddy S, Smith D, Rich M, Leferovich J, Reilly P, Davis B . Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy. Nat Genet. 1996; 13(3):325-35. DOI: 10.1038/ng0796-325. View

12.

Geens M, Mateizel I, Sermon K, De Rycke M, Spits C, Cauffman G . Human embryonic stem cell lines derived from single blastomeres of two 4-cell stage embryos. Hum Reprod. 2009; 24(11):2709-17. PMC: 2763129. DOI: 10.1093/humrep/dep262. View

13.

Reubinoff B, Pera M, Vajta G, Trounson A . Effective cryopreservation of human embryonic stem cells by the open pulled straw vitrification method. Hum Reprod. 2001; 16(10):2187-94. DOI: 10.1093/humrep/16.10.2187. View

14.

Park I, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A . Disease-specific induced pluripotent stem cells. Cell. 2008; 134(5):877-86. PMC: 2633781. DOI: 10.1016/j.cell.2008.07.041. View